Welcome to Uniting doctors

Reimagining the Standard of Care by the medical professional community

Our Story

Our Story

We now have the key to share that opens the door and unlocks the perceived mystery of many health conditions previously not considered comorbidities or related to another specific condition!

What is the mystery disease? Alpha1 Antitrypsin Deficiency!

Our founder Mark Egly, and some of his family have lived this disease and many have given their lives without knowledge they had this genetic flaw. Knowing this condition more fully, will assist millions with improved health and longer life expectancies.

We now have the key to share that opens the door and unlocks the perceived mystery of many health conditions previously not considered comorbidities or related to another specific condition!

Living Dramatically Healthier with the Proper Identification of a Disease with Many Comorbidities!

  • The number 1 genetic killer of adults is Alpha1 Antitrypsin Deficiency!
  • Mark Egly is considerably stronger and healthier today because of Alpha1 Antitrypsin and the detection of a genetic condition associated with Alpha1 Antitrypsin Deficiency. Alpha1 Antitrypsin Deficiency has finally been uncovered, after decades of pure mystery, as the disease that has been taking the lives of other members of Mark's family!
  • By linking Alpha1 Antitrypsin to other ailments and comorbidities, we can find pathways to better health. By uniting great minds in the medical profession, we can help many other families dealing with similar ordeals.

A Small Part of Mark Egly's Personal Medical History and Health Miracle


Over the last 30 years, Mark has had three not-at-fault auto accidents. In two accidents, Mark was hit by individuals texting and hitting Mark with their vehicles at high speeds. These three accidents resulted in multiple back, neck, and shoulder injuries, with fractures. What is the relevance here? The pain Mark experienced from the accidents, and all the previously present inflammation has now diminished immensely. In the future, similar pain for individuals should be controlled and managed significantly better for others with similar pain situations. Over these 30 years, Mark's pain was attributed and related to car accidents, and that typical medication should help. With Alpha1 Antitrypsin and knowledge of the pain source for Mark, the overall pain is being dealt with much healthier methods without the potential side effects of other treatment methods prescribed at the time.

Blood Tests

  • Historically, Mark's blood tests before the diagnosis of Alpha1 Antitrypsin Deficiency always come back perfect by insurance applications and annual physical standards.
  • For 25 years, almost every physician considered Mark a hypochondriac because his blood work was always perfect!
  • Mark's demand for testing for AATD because of his lifelong research and potential diagnosis of AATD in 2018 is what changed his life and health positively. (At the time of Mark's self-diagnosis, only 8,000 individuals had ever been diagnosed with AATD!) Even with complaints of a constant cough for decades, pain, and multiple chest x-rays over the last 30 years, no physician saw fit to test for Alpha1 Antitrypsin Deficiency.

Health Status Improvements Now for Mark with Alpha1 Antitrypsin

  • Mark is no longer bedridden, disabled, and no longer dying quickly.
  • Mark is working as an active contributor to our community again!
  • Undiagnosed with Alpha1 Antitrypsin Deficiency, statistics predict an 85% of mortality for individuals by their 60th birthday. That day has come and gone for Mark, and Mark is extremely healthy with his weekly treatment and healthy life choices.
  • Weight has gone from 149 lbs. at diagnosis time to 190 lbs. at the last weigh-in.
  • Mark's cough has resolved by at least 95%!
  • Mark's loss of lung function has stopped deteriorating! His 2022 pulmonary lung function results were equivalent to his original tests at the time of diagnosis in 2018!
  • Mark has considerably reduced sad and depressing days, improving his health outlook for the future.
  • Significant reduction in pain throughout the entire body for Mark.
  • A significant improvement in personal strength and the drive to move forward with enthusiasm for life.

What has Changed, and Why is it Important to Everyone?

  • Mark was diagnosed with Emphysema and COPD in February of 2018.
  • Mark has been researching since 1976 what was killing his family for the last 150 years. After less than five days of research after his February 2018 diagnosis, Mark demanded a blood test to identify the orphan disease Alpha1 Antitrypsin Deficiency. When results came back for the Alpha1 Antitrypsin Deficiency test, Mark was accurate in his assessment that he was suffering from Alpha1 Antitrypsin Deficiency.
  • The number of people Mark has assisted found with AAT is staggering!
  • Health professionals can now make this diagnosis with a straightforward blood test in one day; versus the current standard of care, which typically takes eight years and four healthcare providers to get the diagnosis for a patient as of 2022
  • We are already saving the lives of many more individuals through proper and earlier detection of this easily treatable condition of Alpha1 Antitrypsin Deficiency!
  • We are identifying patients! Patients to be considered for Alpha1 Antitrypsin infusion and other therapies in the future now that we are identifying significant health comorbidities associated with Alpha1 Antitrypsin!
  • We have made the identification of a disease that has been needlessly killing members of Mark's own family and others in our society for centuries. Why? Because of a previous lack of knowledge and understanding of the full impact of Alpha1 Antitrypsin on the entire body!